Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,500 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 5 May 2020) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 3MB, 203 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website

 

 

Export 1038 results:
Author [ Title(Desc)] Type Year
Filters: First Letter Of Last Name is B  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
B. L. Strom, Schinnar, R., Apter, A. J., Margolis, D. J., Lautenbach, E., Hennessy, S., Bilker, W. B., and Pettitt, D., Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics, N Engl J Med, vol. 349, pp. 1628-35, 2003.
H. P. Booth, Prevost, A. T., and Gulliford, M. C., Access to weight reduction interventions for overweight and obese patients in UK primary care: population-based cohort study, BMJ Open, vol. 5, p. e006642, 2015.
C. Becker, Jick, S. S., and Meier, C. R., ACE inhibitor use and risk of cataract: a case-control analysis, Br J Ophthalmol, 2019.
M. F. Barakat, McDonald, H. I., Collier, T. J., Smeeth, L., Nitsch, D., and Quint, J. K., Acute kidney injury in stable COPD and at exacerbation, Int J Chron Obstruct Pulmon Dis, vol. 10, pp. 2067-77, 2015.
J. Watson, Salisbury, C., Whiting, P., Banks, J., Pyne, Y., and Hamilton, W., Added value and cascade effects of inflammatory marker tests in UK primary care: a cohort study from the Clinical Practice Research Datalink, Br J Gen Pract, vol. 69, pp. e470-e478, 2019.
M. Schmidt, Mansfield, K. E., Bhaskaran, K., Nitsch, D., Sorensen, H. T., Smeeth, L., and Tomlinson, L. A., Adherence to guidelines for creatinine and potassium monitoring and discontinuation following renin-angiotensin system blockade: a UK general practice-based cohort study, BMJ Open, vol. 7, p. e012818, 2017.
B. Hayhoe, Kim, D., Aylin, P. P., Majeed, F. A., Cowie, M. R., and Bottle, A., Adherence to guidelines in management of symptoms suggestive of heart failure in primary care, Heart, 2018.
R. L. Tannen, Barnhart, K. T., and Rubin, J. C., Advantages of large medical record database for outcomes research: Insights into post-menopausal hormone therapy, Learn Health Syst, vol. 3, p. e10193, 2019.
M. Bloechliger, Reinau, D., Spoendlin, J., Chang, S. C., Kuhlbusch, K., Heaney, L. G., Jick, S. S., and Meier, C. R., Adverse events profile of oral corticosteroids among asthma patients in the UK: cohort study with a nested case-control analysis, Respir Res, vol. 19, p. 75, 2018.
C. Tsang, Bottle, A., Majeed, A., and Aylin, P., Adverse events recorded in English primary care: observational study using the General Practice Research Database, Br J Gen Pract, vol. 63, pp. e534-42, 2013.
H. Carreira, Williams, R., Muller, M., Harewood, R., and Bhaskaran, K., Adverse mental health outcomes in breast cancer survivors compared to women who did not have cancer: systematic review protocol, Syst Rev, vol. 6, p. 162, 2017.
A. A. Sultan, West, J., Ban, L., Humes, D., Tata, L. J., Fleming, K. M., Nelson-Piercy, C., and Card, T., Adverse Pregnancy Outcomes Among Women with Inflammatory Bowel Disease: A Population-Based Study from England, Inflamm Bowel Dis, vol. 22, pp. 1621-30, 2016.
H. Kither, Heazell, A., Bruce, I. N., Tower, C., and Crocker, I., Adverse pregnancy outcomes and subsequent development of connective tissue disease in the UK: an epidemiological study, Bjog, 2020.
S. Bou-Antoun, Costelloe, C., Honeyford, K., Mazidi, M., Hayhoe, B. W. J., Holmes, A., Johnson, A. P., and Aylin, P., Age-related decline in antibiotic prescribing for uncomplicated respiratory tract infections in primary care in England following the introduction of a national financial incentive (the Quality Premium) for health commissioners to reduce use of antibiotic, J Antimicrob Chemother, vol. 73, pp. 2883-2892, 2018.
J. D. Lewis and Brensinger, C., Agreement between GPRD smoking data: a survey of general practitioners and a population-based survey, Pharmacoepidemiol Drug Saf, vol. 13, pp. 437-41, 2004.
B. Cai, Xu, W., Bortnichak, E., and Watson, D. J., An algorithm to identify medical practices common to both the General Practice Research Database and The Health Improvement Network database, Pharmacoepidemiol Drug Saf, vol. 21, pp. 770-774, 2012.
S. V. Eastwood, Mathur, R., Atkinson, M., Brophy, S., Sudlow, C., Flaig, R., de Lusignan, S., Allen, N., and Chaturvedi, N., Algorithms for the Capture and Adjudication of Prevalent and Incident Diabetes in UK Biobank, PLoS One, vol. 11, p. e0162388, 2016.
C. J. Beattie, Fulton, R. L., Higgins, P., Padmanabhan, S., McCallum, L., Walters, M. R., Dominiczak, A. F., Touyz, R. M., and Dawson, J., Allopurinol initiation and change in blood pressure in older adults with hypertension, Hypertension, vol. 64, pp. 1102-7, 2014.
F. Lapi, Azoulay, L., Niazi, M. T., Yin, H., Benayoun, S., and Suissa, S., Androgen deprivation therapy and risk of acute kidney injury in patients with prostate cancer, Jama, vol. 310, pp. 289-96, 2013.
A. J. Klil-Drori, Tascilar, K., Yin, H., Aprikian, A., Bitton, A., and Azoulay, L., Androgen Deprivation Therapy and the Incidence of Inflammatory Bowel Disease in Patients With Prostate Cancer, Am J Epidemiol, vol. 184, pp. 15-22, 2016.
J. Assayag, Yin, H., Benayoun, S., Pollak, M. N., Suissa, S., and Azoulay, L., Androgen deprivation therapy and the risk of colorectal cancer in patients with prostate cancer, Cancer Causes Control, vol. 24, pp. 839-45, 2013.
B. M. Hicks, Yin, H., Bladou, F., Ernst, P., and Azoulay, L., Androgen deprivation therapy for prostate cancer and the risk of hospitalisation for community-acquired pneumonia, Thorax, vol. 72, pp. 596-597, 2017.
L. Azoulay, Yin, H., Benayoun, S., Renoux, C., Boivin, J. F., and Suissa, S., Androgen-deprivation therapy and the risk of stroke in patients with prostate cancer, Eur Urol, vol. 60, pp. 1244-50, 2011.
L. Azoulay, Yin, H., Benayoun, S., Renoux, C., Boivin, J. F., and Suissa, S., Androgen-deprivation therapy and the risk of stroke in patients with prostate cancer, Eur Urol, vol. 60, pp. 1244-50, 2011.
J. Busby, McMenamin, U., Spence, A., Johnston, B. T., Hughes, C., and Cardwell, C. R., Angiotensin receptor blocker use and gastro-oesophageal cancer survival: a population-based cohort study, Aliment Pharmacol Ther, vol. 47, pp. 279-288, 2018.
K. Bhaskaran, Douglas, I., Evans, S., Van Staa, T., and Smeeth, L., Angiotensin receptor blockers and risk of cancer: cohort study among people receiving antihypertensive drugs in UK General Practice Research Database, Bmj, vol. 344, p. e2697, 2012.
K. L. Goh, Bhaskaran, K., Minassian, C., Evans, S. J., Smeeth, L., and Douglas, I. J., Angiotensin receptor blockers and risk of dementia: cohort study in UK Clinical Practice Research Datalink, Br J Clin Pharmacol, vol. 79, pp. 337-50, 2015.
R. Hubbard, Venn, A., Lewis, S., and Britton, J., Anitdepressant exposure and risk of Cryptogenic Fibrosing Alveolitis (CFA): A case-control study using the General Practice Research Database (GPRD), vol. 53, p. A11, 1998.
I. Essers, Stolwijk, C., Boonen, A., De Bruin, M. L., Bazelier, M. T., de Vries, F., and van Tubergen, A., Ankylosing spondylitis and risk of ischaemic heart disease: a population-based cohort study, Ann Rheum Dis, vol. 75, pp. 203-9, 2016.
I. Essers, Stolwijk, C., Boonen, A., De Bruin, M. L., Bazelier, M. T., de Vries, F., and van Tubergen, A., Ankylosing spondylitis and risk of ischaemic heart disease: a population-based cohort study, Ann Rheum Dis, vol. 75, pp. 203-9, 2016.
O. van Hecke, Fuller, A., Bankhead, C., Jenkins-Jones, S., Francis, N., Moore, M., Butler, C., and Wang, K., Antibiotic exposure and 'response failure' for subsequent respiratory tract infections: an observational cohort study of UK preschool children in primary care, Br J Gen Pract, vol. 69, pp. e638-e646, 2019.
O. van Hecke, Fuller, A., Bankhead, C., Jenkins-Jones, S., Francis, N., Moore, M., Butler, C., and Wang, K., Antibiotic exposure and 'response failure' for subsequent respiratory tract infections: an observational cohort study of UK preschool children in primary care, Br J Gen Pract, vol. 69, pp. e638-e646, 2019.
V. Palin, Molter, A., Belmonte, M., Ashcroft, D. M., White, A., Welfare, W., and Van Staa, T., Antibiotic prescribing for common infections in UK general practice: variability and drivers, J Antimicrob Chemother, 2019.
H. Ahmed, Farewell, D., Jones, H. M., Francis, N. A., Paranjothy, S., and Butler, C. C., Antibiotic prophylaxis and clinical outcomes among older adults with recurrent urinary tract infection: cohort study, Age Ageing, vol. 48, pp. 228-234, 2019.
C. J. Currie, Berni, E., Jenkins-Jones, S., Poole, C. D., Ouwens, M., Driessen, S., de Voogd, H., Butler, C. C., and Morgan, C. L., Antibiotic treatment failure in four common infections in UK primary care 1991-2012: longitudinal analysis, Bmj, vol. 349, p. g5493, 2014.
C. J. Currie, Berni, E., Jenkins-Jones, S., Poole, C. D., Ouwens, M., Driessen, S., de Voogd, H., Butler, C. C., and Morgan, C. L., Antibiotic treatment failure in four common infections in UK primary care 1991-2012: longitudinal analysis, Bmj, vol. 349, p. g5493, 2014.
D. J. Margolis, Bowe, W. P., Hoffstad, O., and Berlin, J. A., Antibiotic treatment of acne may be associated with upper respiratory tract infections, Arch Dermatol, vol. 141, pp. 1132-6, 2005.
D. J. Margolis, Bowe, W. P., Hoffstad, O., and Berlin, J. A., Antibiotic treatment of acne may be associated with upper respiratory tract infections, Arch Dermatol, vol. 141, pp. 1132-6, 2005.
C. Hopkins, Williamson, E., Morris, S., Clarke, C. S., Thomas, M., Evans, H., Little, P., Lund, V. J., Blackshaw, H., Schilder, A., Philpott, C., Carpenter, J., and Denaxas, S., Antibiotic usage in chronic rhinosinusitis: analysis of national primary care electronic health records, Rhinology, 2019.
F. N. Aberra, Brensinger, C. M., Bilker, W. B., Lichtenstein, G. R., and Lewis, J. D., Antibiotic use and the risk of flare of inflammatory bowel disease, Clin Gastroenterol Hepatol, vol. 3, pp. 459-65, 2005.
F. N. Aberra, Brensinger, C. M., Bilker, W. B., Lichtenstein, G. R., and Lewis, J. D., Antibiotic use and the risk of flare of inflammatory bowel disease, Clin Gastroenterol Hepatol, vol. 3, pp. 459-65, 2005.
K. Richardson, Fox, C., Maidment, I., Steel, N., Loke, Y. K., Arthur, A., Myint, P. K., Grossi, C. M., Mattishent, K., Bennett, K., Campbell, N. L., Boustani, M., Robinson, L., Brayne, C., Matthews, F. E., and Savva, G. M., Anticholinergic drugs and risk of dementia: case-control study, Bmj, vol. 361, p. k1315, 2018.
K. Richardson, Fox, C., Maidment, I., Steel, N., Loke, Y. K., Arthur, A., Myint, P. K., Grossi, C. M., Mattishent, K., Bennett, K., Campbell, N. L., Boustani, M., Robinson, L., Brayne, C., Matthews, F. E., and Savva, G. M., Anticholinergic drugs and risk of dementia: case-control study, Bmj, vol. 361, p. k1315, 2018.
K. Richardson, Fox, C., Maidment, I., Steel, N., Loke, Y. K., Arthur, A., Myint, P. K., Grossi, C. M., Mattishent, K., Bennett, K., Campbell, N. L., Boustani, M., Robinson, L., Brayne, C., Matthews, F. E., and Savva, G. M., Anticholinergic drugs and risk of dementia: case-control study, Bmj, vol. 361, p. k1315, 2018.
D. Saragoussi, Chollet, J., Bineau, S., Chalem, Y., and Milea, D., Antidepressant switching patterns in the treatment of major depressive disorder: a General Practice Research Database (GPRD) Study, Int J Clin Pract, vol. 66, pp. 1079-87, 2012.
R. Gafoor, Booth, H. P., and Gulliford, M. C., Antidepressant utilisation and incidence of weight gain during 10 years' follow-up: population based cohort study, Bmj, vol. 361, p. k1951, 2018.
C. E. Koro, Bowlin, S. J., and Weiss, S. R., Antidiabetic therapy and the risk of heart failure in type 2 diabetic patients: an independent effect or confounding by indication, Pharmacoepidemiol Drug Saf, vol. 14, pp. 697-703, 2005.
[Page last reviewed 5 May 2020]